Amgen Financials

Market Capitalization $149.37 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	35.44
Forward PE	13.44
Price to Sales TTM	$4.59
Price to Book MRQ	$19.84
Enterprise to Revenue	6.17
Enterprise to EBITDA	16.39

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	13.00%
Operating Margin	24.16%
Return on Assets TTM	4.60%
Return on Equity TTM	55.72%

Income Statement

Revenue TTM	$32,533,999,616
Revenue per Share TTM	$60.64
Quarterly Revenue Growth	23.20%
Gross Profit TTM	$19,712,000,000
EBITDA	$13,483,000,000
Net Income to Common TTM	$4,230,000,128
Diluted EPS TTM	$7.84
Quarterly Earnings Growth YoY	63.60%

Balance Sheet

Total Cash MRQ	$9,011,000,320
Total Cash per Share MRQ	$16.76
Total Debt MRQ	$
Total Debt to Equity MRQ	802.42
Current Ratio MRQ	1.32
Book Value per Share MRQ	$14.00

Cash Flow

Operating Cash Flow TTM	$7,256,999,936
Levered Free Cash Flow TTM	$4,574,875,136

AMGN Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	537,532,992
Float Shares	536,043,757
Avg 10 Volume	3,105,970
Avg 30 Volume	None
Shares Short	11,168,292
Short Ratio	2.83
Short % of Shares	2.08%
% Held by Insiders	0.21%
% Held by Institutions	80.76%

Stock Price Summary

Beta	0.60
Fifty Two Week Low	$253.30
Fifty Two Week High	$346.85
Fifty Two Week Change	-13.81%
Day 50 MA	$275.59
Day 200 MA	$304.01

Dividends and Splits

Forward Annual Dividend Rate	$9.52
Forward Annual Dividend Yield	3.46%
Trailing Annual Dividend Rate	$9.13
Trailing Annual Dividend Yield	3.31%
Payout Ratio	113.41%
Dividend Date	2025-03-07
Ex Dividend Date	2025-02-14
Last Split Factor
Last Split Date	1999-11-22